Antitumor activity of rapamycin and octreotide as single agents or in combination in neuroendocrine tumors

被引：0
|
作者：
Moreno, Amy [1 ]
Akcakanat, Argun [1 ]
Munsell, Mark F. [1 ]
Soni, Alpana [1 ]
Yao, James [1 ]
Meric-Bernstam, Funda [1 ]
机构：
[1] Univ Texas MD Anderson Canc Ctr, Houston, TX USA
来源：
MOLECULAR CANCER THERAPEUTICS | 2007年 / 6卷 / 12期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：3583S / 3583S
页数：1
相关论文
共 50 条
  • [41] Rationale and protocol of the MetNET-1 trial, a prospective, single center, phase II study to evaluate the activity and safety of everolimus in combination with octreotide LAR and metformin in patients with advanced pancreatic neuroendocrine tumors
    Pusceddu, Sara
    de Braud, Filippo
    Concas, Laura
    Bregant, Cristina
    Leuzzi, Livia
    Formisano, Barbara
    Buzzoni, Roberto
    TUMORI JOURNAL, 2014, 100 (06): : E286 - E289
  • [42] Inhibition of glucose metabolism in neuroendocrine tumors by lanreotide, sunitinib, and rapamycin
    Rubinek, Tami
    Shabtay-Orbach, Ayelet
    Hesin, Arkadi
    Rubinstein, Tammi
    Wolf, Ido
    CANCER RESEARCH, 2016, 76
  • [43] SYNTHESIS AND IN VITRO ANTITUMOR ACTIVITY OF NEW ANALOGS OF OCTREOTIDE
    Naydenova, E.
    Staykova, S.
    Wesselinova, D.
    Vezenkov, L.
    JOURNAL OF PEPTIDE SCIENCE, 2014, 20 : S139 - S140
  • [44] Antitumor activity of brostallicin on human prostatic cancer: Role of combination with hypomethylating agents
    Broggini, Massimo
    Sabatino, Maria A.
    Geroni, Cristina
    Weitman, Steven W.
    MOLECULAR CANCER THERAPEUTICS, 2007, 6 (12) : 3430S - 3430S
  • [45] Antitumor activity, and antiangiogenic activity of nanoparticle albumin-bound nab-rapamycin in combination with nab-paclitaxel.
    Desai, N.
    Ran, S.
    Volk, L.
    Stutzman, A.
    D 'Cruz, O.
    Trieu, V
    CANCER RESEARCH, 2009, 69 (02) : 239S - 239S
  • [46] A single-centre experience with octreotide in the treatment of different hypersecretory syndromes in patients gastroenteropancreatic with functional neuroendocrine tumors
    Berkovic, Maja Cigrovski
    Altabas, Velimir
    Herman, Davorka
    Hrabar, Davor
    Goldoni, Vesna
    Vizner, Branka
    Zjacic-Rotkvic, Vanja
    COLLEGIUM ANTROPOLOGICUM, 2007, 31 (02) : 531 - 534
  • [47] Antitumor activity of rapamycin in combination with ectopic expression of Beclin 1 in multidrug-resistant cancer cells
    Lee, Michael
    Ahn, Jun-Ho
    Eum, Ki-Hwan
    Kim, Yun-Ki
    FASEB JOURNAL, 2011, 25
  • [48] Role of Octreotide Scan in Localization of Intra-abdominal Neuroendocrine Tumors
    Zaheer, S.
    Kuo, L. E.
    Bartlett, E.
    Wachtel, H.
    Roses, R. E.
    Karakousis, G.
    Kelz, R. R.
    Fraker, D. L.
    ANNALS OF SURGICAL ONCOLOGY, 2015, 22 : S30 - S30
  • [49] High-dose Octreotide Acetate for Management of Gastroenteropancreatic Neuroendocrine Tumors
    Chadha, Manpreet K.
    Lombardo, Jeffrey
    Mashtare, Terry
    Wilding, Gregory E.
    Litwin, Alan
    Raczyk, Cheryl
    Gibbs, John F.
    Kuvshinoff, Boris
    Javle, Milind M.
    Iyer, Renuka V.
    ANTICANCER RESEARCH, 2009, 29 (10) : 4127 - 4130
  • [50] Octreotide LAR extends survival in low hepatic load neuroendocrine tumors
    Fuerst, Mark L.
    FORMULARY, 2013, 48 (07) : 239 - 239
12345